SCHEMBL5209634

SCHEMBL5209634

CCC(C(=O)O)C(=O)c1ccco1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.51
POLB P06746 4/20 0.51
MEN1 O00255 2/20 0.51
AGTR1 P30556 1/20 0.51
PTPN1 P18031 2/20 0.48
CES2 O00748 1/20 0.48
CES1 P23141 1/20 0.48
ERCC5 P28715 1/20 0.46
FEN1 P39748 1/20 0.46
RAB9A P51151 4/20 0.46
NPC1 O15118 3/20 0.46
ALDH1A1 P00352 5/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
GAA P10253 2/20 0.43
RECQL P46063 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
THRB P10828 1/20 0.43
APEX1 P27695 1/20 0.43
HDAC3 O15379 1/20 0.43
TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18660312 0.83 CES2 (0.47) KMT2APOLBMEN1AGTR1CES2
SCHEMBL16046457 0.83 NPC1 (0.47) KMT2APOLBMEN1AGTR1CES2
SCHEMBL8024733 0.80 POLB (0.53) KMT2APOLBMEN1AGTR1PTPN1
SCHEMBL7097301 0.80 KMT2A (0.46) KMT2APOLBMEN1AGTR1ALDH1A1
SCHEMBL28197369 0.79 POLB (0.56) KMT2APOLBMEN1AGTR1PTPN1
SCHEMBL27657264 0.78 MDM2 (0.50) KMT2APOLBMEN1AGTR1PTPN1
SCHEMBL5159829 0.78 KMT2A (0.55) KMT2APOLBMEN1AGTR1PTPN1
SCHEMBL28094278 0.77 KMT2A (0.50) KMT2APOLBMEN1AGTR1PTPN1
SCHEMBL11259918 0.76 ALDH1A1 (0.48) KMT2APOLBMEN1AGTR1CES2
SCHEMBL11859616 0.76 KMT2A (0.56) KMT2APOLBMEN1AGTR1PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1405917-B1 Process for the production of 3-Heteroaryl-3-hydroxy-propionic acid derivatives by enantioselective microbial reduction SALTIGO GMBH (DE) 2013-08-14 EP claimed
EP-1405917-A2 Process for the production of 3-Heteroaryl-3-hydroxy-propionic acid derivatives by enantioselective microbial reduction Bayer Chemicals AG (DE) 2004-04-07 EP claimed
EP-1405917-B1 Process for the production of 3-Heteroaryl-3-hydroxy-propionic acid derivatives by enantioselective microbial reduction SALTIGO GMBH (DE) 2013-08-14 EP disclosed
EP-1611094-B1 PYRAZOLE COMPOUNDS MERCK PATENT GMBH (DE) 2007-06-20 EP disclosed
EP-1611122-B1 SUBSTITUTED PYRAZOLE COMPOUNDS MERCK PATENT GMBH (DE) 2007-06-13 EP disclosed
EP-1611122-A1 SUBSTITUTED PYRAZOLE COMPOUNDS MERCK PATENT GmbH (DE) 2006-01-04 EP disclosed
EP-1611094-A1 PYRAZOLE COMPOUNDS MERCK PATENT GmbH (DE) 2006-01-04 EP disclosed
WO-2004089932-A1 SUBSTITUTED PYRAZOLE COMPOUNDS MERCK PATENT GMBH (DE) 2004-10-21 WO disclosed
WO-2004089888-A1 PYRAZOLE COMPOUNDS MERCK PATENT GMBH (DE) 2004-10-21 WO disclosed
EP-1405917-A2 Process for the production of 3-Heteroaryl-3-hydroxy-propionic acid derivatives by enantioselective microbial reduction Bayer Chemicals AG (DE) 2004-04-07 EP disclosed
EP-1340746-A1 Process for the reduction of 3-heteroaryl-3-oxo-propanoic acid derivatives BAYER AG (DE) 2003-09-03 EP disclosed
US-5434157-A Active against herpes, hepatitis, papovavirus THE UPJOHN COMPANY (US) 1995-07-18 US disclosed